Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-94.06%
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - P/B ratio
P/B ratio as of April 2024 : 0.0072
According to Mallinckrodt Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 0.0072.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Mallinckrodt Pharmaceuticals - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.0072 | -86.9% |
| 2022-12-31 | 0.0552 | 63.36% |
| 2021-12-31 | 0.0338 | 102.53% |
| 2020-12-31 | 0.0167 | -88.97% |
| 2019-12-31 | 0.1512 | -66.83% |
| 2018-12-31 | 0.4560 | 52.68% |
| 2017-12-31 | 0.2986 | -71.45% |
| 2016-12-31 | 1.05 | -35.33% |
| 2015-12-31 | 1.62 | -28.72% |
| 2014-12-31 | 2.27 | -2.08% |
| 2013-12-31 | 2.32 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.20 | 71,893.44% | 🇺🇸 USA |
 General Electric GE | 6.18 | 85,337.58% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.85 | 25,447.97% | 🇮🇱 Israel |